Ocular Therapeutix, Inc.
US ˙ NasdaqGM ˙ US67576A1007

SecurityOCUL / Ocular Therapeutix, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,520,631 shares
Latest Disclosed Value $ 12,879,744
UBS Group AG reports 22.14% increase in ownership of OCUL / Ocular Therapeutix, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,520,631 shares of Ocular Therapeutix, Inc. (US:OCUL) valued at $12,879,745 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 1,244,944 shares of Ocular Therapeutix, Inc.. This represents a change in shares of 22.14% during the quarter. The current value of the position is $13,381,553 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,520,631 275,687 22.14 12,880 -14.78 0.0004
2026-01-29 2025-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,244,944 -3,322 -0.27 15,114 3.57 0.0004
2025-11-13 2025-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,248,266 -716,885 -36.48 14,592 -19.98 0.0023
2025-08-14 2025-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,965,151 630,212 47.21 18,237 86.37 0.0032
2025-05-13 2025-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,334,939 458,393 52.30 9,785 30.73 0.0018
2025-02-14 2024-12-31 13F OCULAR THERAPEUTIX COM 67576A100 876,546 191,770 28.00 7,486 25.65 0.0014
2024-11-14 2024-09-30 13F OCULAR THERAPEUTIX COM 67576A100 684,776 -63,957 -8.54 5,958 16.32 0.0013
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM 67576A100 748,733 265,227 54.85 5,121 16.41 0.0013
2024-05-13 2024-03-31 13F OCULAR THERAPEUTIX COM 67576A100 483,506 392,673 432.30 4,400 986.17 0.0011
2024-02-09 2023-12-31 13F OCULAR THERAPEUTIX COM 67576A100 90,833 37,259 69.55 405 141.07 0.0001
2023-11-09 2023-09-30 13F OCULAR THERAPEUTIX COM 67576A100 53,574 -76,377 -58.77 168 -74.93 0.0001
2023-08-11 2023-06-30 13F OCULAR THERAPEUTIX COM 67576A100 129,951 128,674 10,076.27 671 11,066.67 0.0002
2023-05-12 2023-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,277 0 0.00 7 100.00 0.0000
2023-02-08 2022-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,277 277 27.70 4 -25.00 0.0000
2022-11-10 2022-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,000 -341,228 -99.71 4 -99.71 0.0000
2022-08-10 2022-06-30 13F OCULAR THERAPEUTIX COM 67576A100 342,228 307,344 881.05 1,376 695.38 0.0006
2022-05-16 2022-03-31 13F OCULAR THERAPEUTIX COM 67576A100 34,884 -60,006 -63.24 173 -73.83 0.0001
2022-02-14 2021-12-31 13F OCULAR THERAPEUTIX COM 67576A100 94,890 -231,738 -70.95 661 -79.76 0.0002
2021-11-15 2021-09-30 13F OCULAR THERAPEUTIX COM 67576A100 326,628 -258,165 -44.15 3,266 -60.62 0.0010
2021-08-13 2021-06-30 13F OCULAR THERAPEUTIX COM 67576A100 584,793 33,929 6.16 8,293 -8.25 0.0027
2021-05-12 2021-03-31 13F OCULAR THERAPEUTIX COM 67576A100 550,864 -69,232 -11.16 9,039 -29.58 0.0030
2021-02-11 2020-12-31 13F OCULAR THERAPEUTIX COM 67576A100 620,096 483,347 353.46 12,836 1,133.05 0.0043
2020-11-12 2020-09-30 13F OCULAR THERAPEUTIX COM 67576A100 136,749 -27,847 -16.92 1,041 -24.07 0.0004
2020-07-31 2020-06-30 13F OCULAR THERAPEUTIX COM 67576A100 164,596 131,706 400.44 1,371 741.10 0.0006
2020-05-01 2020-03-31 13F OCULAR THERAPEUTIX COM 67576A100 32,890 -19,805 -37.58 163 -21.63 0.0001
2020-02-14 2019-12-31 13F OCULAR THERAPEUTIX COM 67576A100 52,695 26,812 103.59 208 163.29 0.0001
2019-11-14 2019-09-30 13F OCULAR THERAPEUTIX COM 67576A100 25,883 25,383 5,076.60 79 3,850.00 0.0000
2019-08-14 2019-06-30 13F OCULAR THERAPEUTIX COM 67576A100 500 0 0.00 2 0.00 0.0000
2019-05-14 2019-03-31 13F OCULAR THERAPEUTIX COM 67576A100 500 -1,423 -74.00 2 -75.00 0.0000
2019-02-14 2018-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,923 -13,613 -87.62 8 -92.52 0.0000
2018-11-14 2018-09-30 13F OCULAR THERAPEUTIX COM 67576A100 15,536 -15,734 -50.32 107 -49.29 0.0000
2018-08-14 2018-06-30 13F OCULAR THERAPEUTIX COM 67576A100 31,270 23,770 316.93 211 330.61 0.0001
2018-05-15 2018-03-31 13F OCULAR THERAPEUTIX COM 67576A100 7,500 1,558 26.22 49 88.46 0.0000
2018-02-14 2017-12-31 13F OCULAR THERAPEUTIX COM 67576A100 5,942 -2,243 -27.40 26 -49.02 0.0000
2017-11-14 2017-09-30 13F OCULAR THERAPEUTIX COM 67576A100 8,185 3,035 58.93 51 6.25 0.0000
2017-11-14 2017-06-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 5,150 -2,406 -31.84 48 -31.43 0.0000
2017-08-14 2017-06-30 13F OCULAR THERAPEUTIX COM 67576A100 5,150 -2,406 48
2017-11-14 2017-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 7,556 4,243 128.07 70 150.00 0.0000
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX COM 67576A100 7,556 4,243 70
2017-02-14 2016-12-31 13F OCULAR THERAPEUTIX COM 67576A100 3,313 -2,660 -44.53 28 -31.71 0.0000
2016-11-14 2016-09-30 13F OCULAR THERAPEUTIX COM 67576A100 5,973 2,111 54.66 41 115.79 0.0000
2016-08-12 2016-06-30 13F OCULAR THERAPEUTIX COM 67576A100 3,862 2,362 157.47 19 35.71 0.0000
2016-05-12 2016-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,500 -4,588 -75.36 14 -75.44 0.0000
2016-02-16 2015-12-31 13F OCULAR THERAPEUTIX COM 67576A100 6,088 2,388 64.54 57 9.62 0.0000
2015-11-13 2015-09-30 13F OCULAR THERAPEUTIX COM 67576A100 3,700 3,525 2,014.29 52 1,200.00 0.0000
2015-08-14 2015-06-30 13F OCULAR THERAPEUTIX COM 67576A100 175 -603 -77.51 4 -87.88 0.0000
2015-05-14 2015-03-31 13F OCULAR THERAPEUTIX COM 67576A100 778 216 38.43 33 153.85 0.0000
2015-02-17 2014-12-31 13F OCULAR THERAPEUTIX COM 67576A100 562 562 13 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.